Author Archives: Erika Erdmann

Aerobic Vaginitis (AV) Testing Now Available At BioReference Laboratories

BioReference Laboratories, Inc., along with its specialty women’s health division, GenPath, today announces the launch [...]

17
May
GeneDx Joins Rare Disease Organizations to Support Rare Disease Day 2019
February 28, 2019

Employees Nationwide Participate in Rare Disease Day Virtual Race Campaign GAITHERSBURG, Md., Feb 28, 2019 (GLOBE [...]

BioReference Laboratories Supports Federal Employees Amidst Government Shutdown
January 28, 2019

ELMWOOD PARK, Jan. 28, 2019 – BioReference Laboratories Inc., an OPKO Health Company, today announced that they [...]

BioReference Laboratories Named as Preferred Laboratory with Horizon Healthcare Services Serving Members of Horizon Healthcare Services, Inc.
November 8, 2018

MIAMI, FL NOVEMBER 8, 2018 — BioReference Laboratories, Inc. (BRL), an OPKO Health company and the third largest clinical laboratory [...]

OPKO Plans to Address Draft Local Coverage Determination Published by Novitas Solutions for 4Kscore Test
May 18, 2018

MIAMI, May 18, 2018 (GLOBE NEWSWIRE) — OPKO Health, Inc.(Nasdaq:OPK) today announced that Novitas Solutions, Inc. issued a draft local [...]

OPKO Health Appoints Geoff Monk General Manager at BioReference Laboratories
May 1, 2018

MIAMI, May 01, 2018 (GLOBE NEWSWIRE) — OPKO Health, Inc.(NASDAQ:OPK) today announced the appointment of Geoff Monkas General Manager [...]

OPKO Health Announces Landmark Study Showing 4Kscore® Test is Strong Predictor of Prostate Cancer Mortality Published in European Urology
March 16, 2018

Study of 11,506 men shows that healthy men with an abnormal PSA and a low 4Kscore test result can [...]

OPKO Health Announces Leadership Changes at BioReference Laboratories
January 26, 2018

MIAMI, Jan. 26, 2018 (GLOBE NEWSWIRE) — OPKO Health, Inc.(NASDAQ:OPK), announces that Gregory Henderson, M.D., Ph.D., has resigned from [...]

OPKO’S GeneDx Announces Research Collaboration with Radboud University Medical Center
January 12, 2018

MIAMI, Jan. 12, 2018 (GLOBE NEWSWIRE) — OPKO Health, Inc.(NASDAQ:OPK), announces today that GeneDx, Inc., a subsidiary of OPKO’s BioReference [...]

OPKO’s BioReference Laboratories and The Garage Announce National Strategic Affiliation to Enhance Value-Based Care
September 19, 2017

MIAMI and ORLANDO, Fla., Sept. 19, 2017 (GLOBE NEWSWIRE) — OPKO Health, Inc.(NASDAQ:OPK) (“OPKO” or “the Company”), announces that BioReference Laboratories, [...]